High Ki-67 (≥10%) in breast cancer patients with moderate risk for recurrence (including those with 1–3 positive axillary lymph nodes) was an independent prognostic factor for shorter disease-free survival and overall survival [26], but a cutoff value of 10% in our study was not significantly associated with metastases-free survival or overall survival (Table S1). The gene discussed is MKI67; the disease is breast cancer.